Dr. Diemert is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
VA Medical Center Washington DC
50 Irving Street NW
Washington, DC 20422Phone+1 202-745-8695Fax+1 202-842-7689
Education & Training
- University of AlbertaClass of 1995
Certifications & Licensure
- MD State Medical License 2001 - 2026
- DC State Medical License 2007 - 2024
Clinical Trials
- Phase 1 Trial of Na-ASP-2 Hookworm Vaccine in Previously Infected Brazilian Adults Start of enrollment: 2007 May 01
- Safety and Immunogenicity of a Human Hookworm Candidate Vaccine With or Without Additional Adjuvant in Brazilian Adults Start of enrollment: 2011 Nov 01
- An Evaluation of a Novel Food Product in Adults Residing in an Area Endemic for Helminths Start of enrollment: 2011 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 6054 citationsEfficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.Lindsey R. Baden, Hana M. El Sahly, Brandon Essink, Karen L. Kotloff, Sharon E. Frey
The New England Journal of Medicine. 2021-02-04 - 1413 citationsSoil-transmitted helminth infections: ascariasis, trichuriasis, and hookwormJeffrey M. Bethony, Simon Brooker, Marco Albonico, Stefan M. Geiger, Alex Loukas
Lancet. 2006-05-06 - 29 citationsYear-to-Year Variation in the Age-Specific Incidence of Clinical Malaria in Two Potential Vaccine Testing Sites in Mali With Different Levels of Malaria Transmission I...Alassane Dicko, Issaka Sagara, David Diemert, Moussa Sogoba, Mohamed B. Niambele
The American Journal of Tropical Medicine and Hygiene. 2007-12-01
Press Mentions
- Bird Flu: U.S. Could Produce and Ship 100 Million Vaccine Doses Within MonthsMay 7th, 2024
- Pfizer RSV Vaccine Trials Show Protection for Infants and Older AdultsApril 7th, 2023
- mRNA HIV Vaccine Achieves 97 Percent Efficacy in SMHS Human TrialsJanuary 30th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: